What We're Reading
Industry reads hand-picked by our editors
Sep 24, 2021
-
The New York Times
A ‘Race-Free’ Approach to Diagnosing Kidney Disease
-
NPR
NY Hospitals Worry About Staff Shortages As Monday Vaccine Deadline Approaches
-
MedCity News
Remote patient monitoring use is on the rise, but reimbursement needs to catch up
-
The Verge
Most dermatology algorithms don’t have transparent data
Sep 23, 2021
-
The Hill
Biden under pressure to expand rapid COVID-19 testing
-
Kaiser Health News
At an Overrun ICU, ‘the Problem Is We Are Running Out of Hallways’
-
Bloomberg
Ex-Defense Chief Mattis Says He Trusted Holmes, Lost Money in Theranos
-
TCTMD
EXPLANT-TAVR: Data Spur Conversation About Balancing Risk and Lifetime Management
Sep 22, 2021
-
The New York Times
‘I Just Cry All the Time’: Non-Covid Patients Despair Over Delayed Care
-
NPR
The FDA Has Been Without A Permanent Leader For 8 Months, As COVID Cases Climb
-
MedPage Today
Low Risk and Bicuspid Anatomy: A Passable Combination for TAVR Thus Far
-
TCTMD
Coronary Revascularization Benefits Even Latecomer STEMI: FAST-MI Registry
Sep 21, 2021
Sep 20, 2021
-
USA TODAY
Labs are charging up to $14,000 for COVID-19 tests. Insurers claim 'price gouging.'
-
STAT
Winter is coming, again: What to expect from Covid-19 as the season looms
-
TCTMD
Renal Denervation a Third Option for Hypertension, European Experts Say
-
MedCity News
Cala hopes real-world data on essential tremor device will win over payers
Sep 17, 2021
-
The New York Times
Idaho allows overwhelmed hospitals across the state to ration care if necessary.
-
Fierce Biotech
Smiths Medical recalls nearly 30 years' worth of fluid warmers due to risk of aluminum exposure
-
The Atlantic
Theranos and COVID-19 Testing Are Mirror-Image Cautionary Tales
-
TCTMD
DCB Match DES for Treating Coronary In-Stent Restenosis: European Registry
Sep 16, 2021
-
NPR
Overwhelmed With COVID Patients, Oregon Hospitals Postpone Surgeries And Cancer Care
-
Financial Times
Tobacco group Philip Morris wins control of inhaler company Vectura
-
STAT
Digital health measures are gaining traction, but research on privacy and ethics is lagging
-
Axios
CRISPR companies aim to bring gene editing to the market — and beyond
